A double-blind placebo-controlled study to evaluate endometrial safety and gynaecological symptoms in women treated for up to 5 years with tamoxifen or placebo – A substudy for IBIS I Breast Cancer Prevention Trial-Reference-Cited by-同舟云学术

A double-blind placebo-controlled study to evaluate endometrial safety and gynaecological symptoms in women treated for up to 5 years with tamoxifen or placebo – A substudy for IBIS I Breast Cancer Prevention Trial

Published:2013-01 Issue:1 Volume:49 Page:45-51
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Palva Tiina,Ranta Hannu,Koivisto Anna-Maija,Pylkkänen Liisa,Cuzick Jack,Holli Kaija

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference16 articles.

1. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study;Fisher;J Natl Cancer Inst,1998

2. Overview of the main outcomes in the breast-cancer prevention trials;Cuzick;Lancet,2003

3. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers;Fornander;Lancet,1989

4. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen;Lahti;Obstet Gynecol,1993

5. Adjuvant tamoxifen therapy for early stage breast cancer and secondary primary malignancies;Rutqvist;J Natl Cancer Inst,1995

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Guideline No. 451: Asymptomatic Endometrial Thickening in Postmenopausal Women;Journal of Obstetrics and Gynaecology Canada;2024-07

2. Directive clinique no 451 : Épaississement asymptomatique de l’endomètre chez les femmes ménopausées;Journal of Obstetrics and Gynaecology Canada;2024-07

3. Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer;Breast Cancer;2024-06-15

4. Value of endometrial thickness in diagnosis of endometrial hyperplasia during selective estrogen receptor modulator therapy in premenopausal breast cancer patients;Journal of Gynecology Obstetrics and Human Reproduction;2021-10

5. Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I);Journal of Clinical Oncology;2017-08-10